Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £2.44m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Small caps: Cineworld, Aortech, African Eagle

Mon, 24th May 2010 07:52
Cinema chain Cineworld has signed a deal with Quintain Estates for a new multi-screen cinema at Wembley City, the retail park next door to Wembley station. Cineworld has signed a 25 year lease for a new nine screen cinema which will seat 1,800 people in total and is scheduled to open in 2013. It will be located adjacent to Wembley Stadium and Wembley Arena, forming a central part of the 280,000 sq ft leisure and retail hub. Construction is expected to commence on the site in 2011.Biomaterials and medical devices group Aortech today announced a non-exclusive technology licence and material supply agreement with a multi-billion dollar NYSE listed company to use the group's proprietary biostable co-polymer Elast-Eo as an integral part of a drug delivery platform for urological catheters.African Eagle is "delighted" with results of its phase 2 column and tank leach tests at the Dutwa nickel project in Tanzania.The tests show that Dutwa ore could be processed by either heap leaching or tank leaching at normal atmospheric pressure, without recourse to the high cost and hi-tech complications of high pressure acid leach (HPAL).Green technology company Ultima Networks made a pre-tax profit of £214,000 in 2009, down from £281,000 the previous year, on revenue down to £1.87m from £1.98m. "There remain challenges ahead in the economic conditions we face which will have an impact on all divisions of the business but we are confident that the milestones reached in 2009 will allow us to grow across all areas of the group," the firm said.It's also confident it will be able to raise enough money to build the solar parks planned for southern Italy.ValiRx, the biotech firm focused on cancer diagnostics and therapeutics for personalised medicine, has added an over the counter Chlamydia self-testing kit to its range of health screening products.The company has signed an agreement to market Biovei's Chlamydia kit in the UK and Ireland under ValiRx's SELFCheck brand. The SELFCheck Chlamydia kit will provide a test result within about 10 minutes, compared to a lag of four to five days for a laboratory test. Trading systems developer Patsystems said results for the year to end of April were in line with management's expectations while the company's strong pipeline underpins its belief that 2010 will be another strong year for the group."I am pleased to report that 2010 has started as strongly as we expected with the addition of Bursa Malaysia to our client list, good progress on several other sales prospects and continued double digit growth in our existing Asian client base," said Richard Last, the company's chairman.Oil and gas firm Roxi Petroleum narrowed pre-tax losses to $33.4m against the loss of $94.5m predominantly due to lower admin costs. "These are exciting times for Roxi and its shareholders, as we remain focused on increasing shareholder value in the near term. We are looking forward to a very active and productive period ahead of us," he said.Stratex International rose after the exploration and development company announced "positive results" from detailed sampling of the company's Megenta hot spring gold discovery in Ethiopia.Shares in Max Petroleum fell back after the Kazakhstan-focused oil and gas developer said reservoirs encountered during drilling at the Borkyldakty Field were 'structurally lower than expected, at or below their respective oil-water contacts.'

Related News

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
27 May 2026

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case
15 May 2026

TRADING UPDATES: IAG launches new buyback; Forgent settles legal case

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

WINNERS & LOSERS: Kendrick drilling results; Blackbird new approach
15 May 2026

WINNERS & LOSERS: Kendrick drilling results; Blackbird new approach

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

ValiRx News

ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal
4 Aug 2025

ValiRx subsidiary Inaphaea agrees exclusive PredictRx licensing deal

(Alliance News) - ValiRx PLC on Monday said subsidiary Inaphaea BioLabs has agreed an exclusive licensing deal with Dominion Biotech Ltd for Inaphaea'...

CORRECT: Stocks rise, UK data paints "gloomy" picture
20 Jun 2025

CORRECT: Stocks rise, UK data paints "gloomy" picture

(Corrects the name of the AJ Bell analyst quoted.)

Ambrose exercises ValiRx oncology option worth up to £16m
20 Jun 2025

Ambrose exercises ValiRx oncology option worth up to £16m

(Sharecast News) - ValiRx confirmed on Friday that Ambrose Healthcare has exercised its option to license the VAL401 oncology asset, in a deal worth u...

LONDON MARKET MIDDAY: Stocks rise, UK data paints "gloomy" picture
20 Jun 2025

LONDON MARKET MIDDAY: Stocks rise, UK data paints "gloomy" picture

(Alliance News) - Stock prices in London were higher at midday on Friday, amid a slight lull in tensions over the Israel-Iran conflict after US Presid...

ValiRx signs licence with Ambrose worth GBP16 million plus royalties
20 Jun 2025

ValiRx signs licence with Ambrose worth GBP16 million plus royalties

(Alliance News) - ValiRx PLC shares surged on Friday as it said Ambrose Healthcare Ltd has exercised its option to licence its VAL401 asset for GBP16 ...

ValiRx subsidiary enters evaluation agreement with Omios Biologics
3 Jun 2025

ValiRx subsidiary enters evaluation agreement with Omios Biologics

(Alliance News) - ValiRx PLC on Tuesday said subsidiary Cytolytix Ltd has entered an evaluation and material transfer agreement with California-based ...

IN BRIEF: ValiRx extends agreement with Dominion Biotech
12 May 2025

IN BRIEF: ValiRx extends agreement with Dominion Biotech

ValiRx PLC - Essex-based life sciences company focusing on early-stage cancer therapeutics and women's health - signs an extension to the evaluation a...

TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract
4 Apr 2025

TRADING UPDATES: Strategic Minerals sales up; 4Global wins contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: